以追求身心完美為名：生活機能醫藥對健康照護的危害

In the Name of Pursuing Betterness: The Potential Menance of Lifestyle Medicines to Health

丁志音(Chih-Yin Lew-Ting) ； 劉芳助(Fang-Zhu Liu) ； 李袖瑜(Hsiu-Yu Li)

《台灣公共衛生雜誌》 26卷6期 (2007/12) Pp. 443-451

https://doi.org/10.6288/TJPH2007-26-06-01

摘要

2自1998年繼sildenafil（Viagra威而剛）及其後fluoxetine（Prozac百憂解）的問世及使用的急速狂升後，類似的藥物便廣泛被應用於諸多生活方式問題的介入，以便修飾、提升身心的狀態，來強化外觀的、認知及心理的、社會的特殊功能的表現，試圖達到特定或整體的完美與快樂。本文以生活機能醫藥為例，來探討健康強化科技的興起對醫療照護體系甚至人類生活所帶來的衝擊。除了提出生活機能醫藥的定義與範疇外，本文主要由三個層面來探討生活機能醫藥對健康照護體系與人類健康的長遠影響：操弄需求與創造市場、對醫療照護的衝擊與挑戰、以及超越醫療照護的人類本質改變。綜合言之，健康強化科技如生活方式醫藥者，涉及龐大的商業利益，可使健康照護體系與醫學專業產生徹底的質變。除了危及病人安全與真正疾病治療的品質之外，將邁向無止境的人體甚至情緒與心性改造，其終極作用，難於估量。政策制訂者及學術界宜開始關切相關科技產品的使用趨勢與可能影響，並應著手發展管制措施。

關鍵字

生活機能醫藥 ； 健康強化科技 ； 健康照護牟利化 ； 醫療化

並列摘要

Since 1998 when sildenafil (Viagra) and fluoxetine (Prozac) were first presented and subsequently increased rapidly in use, lifestyle drugs as such have been widely used to tackle various lifestyle problems, aiming to modify and enhance the state of mind and body. This article takes the lifestyle medicines as an example to elucidates how health enhancement technologies may influence health care system and human health. In addition to exploring the definition and scope of lifestyle medicines, the article examines the following three aspects pertaining to the issue: needs manipulation and the creation of markets, impacts on health care system, and, beyond health care, the alteration of human essence. In sum, Health enhancement technology such as lifestyle medicines could change the imperatives of health care system and the nature of medicine, not only endangering patient safety and quality of care but also turning to an everlasting modification in human body and mind. Health policymakers and the academic community should begin investigating the current consumption of lifestyle medicines and its possible impacts, and develop regulatory policies accordingly.

並列關鍵字

Lifestyle medicines ； health enhancement technology ； profitalization of health care ； medicalization

參考文獻

(1998).Go on, it`s good for you [Editorial].The Economist.348,51-52.

()。

Ashworth M,Clement S,Wright M.(2002).Demand, appropriateness and prescribing of `lifestyle drugs`: a consultation survey in general practice.Fam Pract.19,236-241.

Atkinson T.(2002).Lifestyle drug market booming.Nat Med.8,909.

Bell RA,Kravitz RL,Wikes MS.(1999).Direct-to-consumer prescription drug advertising and the public.J Gen Intern Med.14,651-657.